- Isoray (NYSE:ISR) shares jump 20% after it says that five papers will be presented at the annual meeting of the American Brachytherapy Society that the company expects will extoll the virtues of its Cesium-131 internal radiation therapy treatment.
- Isoray "believes that all studies will show exceptional results realized in all areas of the body where Cesium-131, or the physics associated with Cesium-131, was used." (PR)
Isoray expects five positive presentations at major conference
Recommended For You
More Trending News
About CATX Stock
Related Stocks
Symbol | Last Price | % Chg |
---|---|---|
CATX | - | - |
Perspective Therapeutics, Inc. |